Familial Partial Lipodystrophy Type 3 (FPLD3): A Patient Guide

Familial Partial Lipodystrophy Type 3 (FPLD3) is a rare, inherited condition that fundamentally alters how your body develops and stores fat. It is caused by a pathogenic variant in the PPARG gene, which serves as a master regulator for fat cell growth and storage ^[1]. Because of this genetic change, the fat tissue just under your skin—particularly in your arms, legs, and hips—cannot expand or function properly to store the energy your body takes in from food ^[2]. This loss of fat, known as lipoatrophy, is often subtle and typically begins to appear during adolescence or early adulthood ^[2].

The central challenge of FPLD3 is not just the physical change in appearance, but how inadequate fat storage alters how your body handles fatty acids and lipids. Because your body lacks enough healthy storage space under the skin, it promotes ectopic fat deposition—meaning fat accumulates in organs like the liver and muscles where it does not belong ^[3]. This ectopic fat can lead to severe metabolic complications, including extreme hypertriglyceridemia (high blood fats), profound insulin resistance, early-onset diabetes, and fatty liver disease ^[2][4]. While the physical signs may be mild, the internal metabolic strain can be severe, although the exact severity varies significantly from person to person ^[5].

Living with FPLD3 requires a proactive, lifelong approach to managing these metabolic risks. The most immediate concern for many patients is the risk of acute pancreatitis, a painful and potentially life-threatening inflammation of the pancreas that can be triggered by dangerously high triglyceride levels ^[6]. Consequently, the foundation of care involves a combination of individualized dietary management guided by a dietitian, targeted medications to lower lipids and blood sugar, and regular monitoring of organ health ^[7]. Because the condition affects multiple systems, management is most effective when guided by a multidisciplinary team of specialists ^[7].

While a diagnosis of FPLD3 can feel overwhelming, it provides a crucial roadmap for your health. Identifying the condition allows you and your care team to move beyond treating symptoms and begin addressing the underlying biological cause of your metabolic challenges ^[8]. With the right monitoring and a personalized treatment plan, it is possible to manage the risks of FPLD3 and maintain a focus on your long-term well-being ^[7].